openPR Logo
Press release

Impact of Existing and Emerging Staphylococcus Aureus Testing Market Trends 2017-2027

01-29-2018 12:14 PM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Impact of Existing and Emerging Staphylococcus Aureus Testing

A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus Aureus testing. The extensive use of Staphylococcus Aureus testing boosts the market growth over the forecast period. Innovation in Staphylococcus Aureus testing gives the accuracy, reliability, efficiency for the end user is expected to fuel the market growth. The use of Staphylococcus Aureus testing in food industries also creates tremendous opportunity during the forecast period.

Staphylococcus Aureus Testing Market: Drivers and Restraint

Growing incidence of Staph infections is the major factor driving the growth of global staphylococcus Aureus testing market. The inappropriate sanitary environment is the major cause for the spread of Staph infections. Staphylococcus Aureus screening is the mandatory screening test prior to taking insulin and growing awareness of bacterial infection across the globe is expected to push the market growth. Advanced rapid diagnostic tests availability also boost the growth of Staphylococcus Aureus Testing Market over the forecast period. However, inadequate reimbursement in developing the region and limited access to regular healthcare may be the restraints for the global staphylococcus Aureus testing market.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-5284

Staphylococcus Aureus testing Market: Segmentation

The global market for Staphylococcus Aureus testing segmented by product type, modality, material, end user, and region:

Segmented by Test Type

Coagulase Test

Ancillary Tests

Agar-Based Tests

Nucleic Acid Amplification Tests

Segmented by Application

Pharmaceutical

Clinical

Food Testing

Other

Segmented by End User

Hospitals

Diagnostic Clinics

Food Testing laboratories

Others

Segmented by Region

North America

Latin America

Western Europe

Eastern Europe

APEJ(Asia-Pacific Excluding Japan)

Japan

The Middle East and Africa

Staphylococcus Aureus testing Market: Overview

Huge competition in the market is due to the increased number of service providers. High efficiency and less price on the testing service are the factors for survival in the market. According to the SENTRY Antimicrobial Surveillance Program the prevalence of Staphylococcus Aureus related disease in North America (26.0%), Latin America ( 21.6%) and in Europe ( 19.5%).

By Test type, Staphylococcus Aureus testing can be segmented into Coagulase Test, Ancillary Tests, Agar-Based Tests and Nucleic Acid Amplification Tests

By Application, the global Staphylococcus Aureus testing market is segmented into Pharmaceutical, Clinical, food testing and other

By End-user, Staphylococcus Aureus testing can be segmented into Segmented into Hospitals, Diagnostic Clinics, Food Testing laboratories and others

By region, Staphylococcus Aureus testing market is segmented into North America, Western Europe, Eastern Europe, Latin America, Asia-Pacific excluding Japan, Japan and the Middle East and Africa

Request Report TOC @ https://www.futuremarketinsights.com/toc/rep-gb-5284

Staphylococcus Aureus testing Market: Region-wise Outlook

By region, global Staphylococcus Aureus testing market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, APEJ (Asia-Pacific Excluding Japan), Japan and Middle East & Africa. North America followed by Europe will continue to dominate the global Staphylococcus Aureus testing market attributed to high incidence. Furthermore, the newly developed product in the Staphylococcus Aureus testing is also expected to result in higher demand for Staphylococcus Aureus testing market globally over the forecast period. Asia Pacific excluding Japan is expected to be the emerging region in the global Staphylococcus Aureus testing market.

Staphylococcus Aureus testing Market: Key Market Participants

The key players in the Staphylococcus Aureus testing market are Abbott Laboratories Inc., Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Thermo Fisher Scientific Inc., Roche Diagnostics (H. Hoffman-La Roche Ltd.), STD Rapid Test Kits etc. among others.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Impact of Existing and Emerging Staphylococcus Aureus Testing Market Trends 2017-2027 here

News-ID: 920337 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Aureus

Methicillin-Resistant Staphylococcus Aureus Testing Market Size, Share, Developm …
LP INFORMATION offers a latest published report on Methicillin-Resistant Staphylococcus Aureus Testing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Methicillin-Resistant Staphylococcus Aureus Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million
Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital
Vancomycin-Resistant Staphylococcus aureus Infections Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2017, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) pipeline landscape. Vancomycin resistant staphylococcus infection is a condition caused by bacteria (germs) . This infection occurs when bacteria, called Staphylococcus aureus or Staph, becomes resistant (not killed) to the antibiotic medicine vancomycin. Risk factors include taking strong antibiotics the wrong
Market Forecast Report on Staphylococcus Aureus Testing Market 2017 – 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus